Synapse Open Synapse
Biology

Next-gen RNAi drugmaker City prices $200M IPO

BioPharma Dive · · 2 min read

The offering will support a trio of medicines in or nearing clinical testing, as well as earlier research into RNAi treatments that get into tissues outside the liver.

Latest from BioPharma Dive